Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decrease of 23.5% from the March 31st total of 1,700 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio is currently 0.0 days.

Revelation Biosciences Price Performance

Shares of REVBW stock remained flat at $0.01 during trading hours on Tuesday. 4,632 shares of the company were exchanged, compared to its average volume of 73,298. The company’s fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.01. Revelation Biosciences has a 1-year low of $0.01 and a 1-year high of $0.03.

About Revelation Biosciences

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.